Anti-Hu CD30 Purified

Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Dry Ice Shipment: No

Alternative Products

Cat	Name
MBS1800421-01	Anti-Hu CD30 Purified
MBS1801186-01	Anti-Hu CD30 Purified
MBS1800421-02	Anti-Hu CD30 Purified
MBS1801186-02	Anti-Hu CD30 Purified
MBS1800422-02	Anti-Hu CD30 FITC
MBS1801189-01	Anti-Hu CD30 PE
MBS1800423-01	Anti-Hu CD30 PE
MBS1801189-02	Anti-Hu CD30 PE
MBS1801188-01	Anti-Hu CD30 FITC
MBS1801188-02	Anti-Hu CD30 FITC

CAT:

270-11-153-C025

Size:

0.025 mg

Price:

Ask

For price, please contact [email protected].

Anti-Hu CD30 Purified

Clone: Ber-H8
Format: Purified
Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
References & Citations: *Aalberse JA, Kapitein B, de Roock S, Klein MR, de Jager W, van der Zee R, Hoekstra MO, van Wijk F, Prakken BJ: Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60). PLoS One. 20116(9):e24119., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=aalberse+ja+kapitein+b+de+roock+s ,*Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood. 1995 Jan 185(1):1-14., URL: http://www.ncbi.nlm.nih.gov/pubmed/7803786 ,*Berro AI, Perry GA, Agrawal DK: Increased expression and activation of CD30 induce apoptosis in human blood eosinophils. J Immunol. 2004 Aug 1173(3):2174-83., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=berro+ai+perry+ga ,*Franke AC, Jung D, Ellis TM: Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies. Hybridoma. 2000 Feb19(1):43-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=franke+ac+jung+d+ellis+tm ,*Matsumoto K, Terakawa M, Miura K, Fukuda S, Nakajima T, Saito H: Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro. J Immunol. 2004 Feb 15172(4):2186-93., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=matsumoto+k+terakawa+m+miura+k,
Other References: *Wright CW, Rumble JM, Duckett CS: CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells. J Biol Chem. 2007 Apr282(14):10252-62. , URL: https://www.ncbi.nlm.nih.gov/pubmed/17261581?ordin,*Zeiser R, Nguyen VH, Hou JZ, Beilhack A, Zambricki E, Buess M, Contag CH, Negrin RS: Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. Blood. 2007 Mar 1109(5):2225-33., URL: https://www.ncbi.nlm.nih.gov/pubmed/17068147?ordin,*Kusanovic JP, Romero R, Hassan SS, Gotsch F, Edwin S, Chaiworapongsa T, Erez O, Mittal P, Mazaki-Tovi S, Soto E, Than NG, Friel LA, Yoon BH, Espinoza J: Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med. 2007 Aug 28:1-12, URL: https://www.ncbi.nlm.nih.gov/pubmed/17853188?ordin,*Bekiaris V, Withers D, Glanville SH, McConnell FM, Parnell SM, Kim MY, Gaspal FM, Jenkinson E, Sweet C, Anderson G, Lane PJ: Role of CD30 in B/T segregation in the spleen. J Immunol. 2007 Dec 1179(11):7535-43., URL: https://www.ncbi.nlm.nih.gov/pubmed/18025198?ordin,*Polte T, Behrendt AK, Hansen G: Direct evidence for a critical role of CD30 in the development of allergic asthma. J Allergy Clin Immunol. 2006 Oct118(4):942-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/17030250?ordin,*Kennedy MK, Willis CR, Armitage RJ: Deciphering CD30 ligand biology and its role in humoral immunity. Immunology. 2006 Jun118(2):143-52., URL: https://www.ncbi.nlm.nih.gov/pubmed/16771849?ordin,*Fischer M, Harvima IT, Carvalho RF, Möller C, Naukkarinen A, Enblad G, Nilsson G: Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest. 2006 Oct116(10):2748-56., URL: https://www.ncbi.nlm.nih.gov/pubmed/16964309?ordin,*Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA: CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease. J Immunol. 2004 Sep 1173(5):2933-41., URL: https://www.ncbi.nlm.nih.gov/pubmed/15322151?ordin,

Complementary Product Range

Our range of products, including Anti-Hu CD30 Purified, falls within the same field of application and can be used across various research projects. These products are carefully selected for their high performance and reliability, supporting the diverse needs of modern laboratories. Whether for ongoing studies or future experiments, they are designed to help researchers achieve their scientific goals. Here are some related products that may be of interest for similar or future applications:

Each item in our collection, is tested for precision and quality, ensuring dependable solutions for your research. As we continue to incorporate the latest advancements, Gentaur ensures that our product range remains relevant and versatile, providing you with the tools needed for both current and future projects.

Find us on

Cat	Name
11-455-C100	Anti-Hu CD30 Purified
11-153-C025	Anti-Hu CD30 Purified
11-455-C025	Anti-Hu CD30 Purified
11-153-C100	Anti-Hu CD30 Purified
1A-455-T100	Anti-Hu CD30 APC
1F-455-T100	Anti-Hu CD30 FITC
1P-153-T025	Anti-Hu CD30 PE
1P-455-T025	Anti-Hu CD30 PE
1P-455-T100	Anti-Hu CD30 PE
1P-153-T100	Anti-Hu CD30 PE